Robust Bruton's Tyrosine Kinase (BTK) Degradation with NX-5948, an Oral BTK Degrader, in a First-in-Human Phase 1a Trial in Relapsed/Refractory B cell Malignancies

Kim Linton; Francesco Forconi; David Lewis; John Riches; Dima El-Sharkawi; Mary Gleeson; Sarah G. Injac; Srinand Nandakumar; May Tan; Ganesh Cherala; Graham P. Collins

Robust Bruton's Tyrosine Kinase (BTK) Degradation with NX-5948, an Oral BTK Degrader, in a First-in-Human Phase 1a Trial in Relapsed/Refractory B cell Malignancies

Kim Linton, Francesco Forconi, David Lewis, John Riches, Dima El-Sharkawi, Mary Gleeson, Sarah G. Injac, Srinand Nandakumar, May Tan, Ganesh Cherala, Graham P. Collins

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S48-S48
Number of pages	1
Journal	American Journal of Hematology
Volume	98
Publication status	Published - Oct 2023

Cite this

@article{8c761933730145a58d65513c551ce0f3,

title = "Robust Bruton's Tyrosine Kinase (BTK) Degradation with NX-5948, an Oral BTK Degrader, in a First-in-Human Phase 1a Trial in Relapsed/Refractory B cell Malignancies",

author = "Kim Linton and Francesco Forconi and David Lewis and John Riches and Dima El-Sharkawi and Mary Gleeson and Injac, {Sarah G.} and Srinand Nandakumar and May Tan and Ganesh Cherala and Collins, {Graham P.}",

year = "2023",

month = oct,

language = "English",

volume = "98",

pages = "S48--S48",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Robust Bruton's Tyrosine Kinase (BTK) Degradation with NX-5948, an Oral BTK Degrader, in a First-in-Human Phase 1a Trial in Relapsed/Refractory B cell Malignancies

AU - Linton, Kim

AU - Forconi, Francesco

AU - Lewis, David

AU - Riches, John

AU - El-Sharkawi, Dima

AU - Gleeson, Mary

AU - Injac, Sarah G.

AU - Nandakumar, Srinand

AU - Tan, May

AU - Cherala, Ganesh

AU - Collins, Graham P.

PY - 2023/10

Y1 - 2023/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001098086400077&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0361-8609

VL - 98

SP - S48-S48

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -

Robust Bruton's Tyrosine Kinase (BTK) Degradation with NX-5948, an Oral BTK Degrader, in a First-in-Human Phase 1a Trial in Relapsed/Refractory B cell Malignancies

Other files and links

Cite this